Functions of Tau protein in human neural cells

Tau蛋白在人类神经细胞中的功能

基本信息

  • 批准号:
    10658624
  • 负责人:
  • 金额:
    $ 26.99万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-04-15 至 2025-03-31
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract Tau protein, encoded by the MAPT gene, is a neuronally enriched protein with an established role as a microtubule-binding protein. Abnormal accumulation of tau protein is a neuropathological hallmark of several neurodegenerative diseases, including Alzheimer’s disease (AD) and frontotemporal dementia (FTD). Dominant mutations in the MAPT gene are present in inherited FTD, indicating that tau is causal in neurodegenerative disease. However, whether these mutations lead to loss-of-function, gain-of-function or the acquisition of a novel function is unknown. Furthermore, although there are no mutations in MAPT that cause inherited AD, how alterations in tau function contribute to dysfunction in neural cells and pathological aggregation of tau protein are still incompletely understood. These issues have not been resolved, largely because the functions of the tau protein have not been conclusively determined. While highly expressed in neurons, tau is expressed in other CNS cell types and has been linked to cellular localizations ranging from the nucleolus to the plasma membrane. Furthermore tau-interacting proteins display a range of cellular functions including gene regulation, membrane transport, RNA binding and metabolism and cytoskeletal elements. Together this suggests a role for tau protein in central nervous system cells beyond microtubule stabilization. Many studies have examined the effects of pathological tau, but only a limited number of studies have investigated the cellular functions of wild type, endogenous tau. Examining cellular phenotypes in the absence of tau is one approach to understand its normal function. To date, most studies have studied tau deficiency using rodent models or transformed human cell lines and these studies show various and sometimes conflicting results. In this study, we will use our expertise in human induced pluripotent stem cell technology to study loss of tau function in human neural cultures and cortical organoids. We will use CRISPR/Cas9 to disrupt the human tau reading frame, generating tau-KO cell lines. We will then pursue both unbiased transcriptomic profiling and hypothesis-based experiments examining molecular and physiological consequences in neurons and astrocytes deficient in tau expression. We have generated pilot data indicating a strong up-regulation of pathways involved in neuroimmune function in tau-KO cortical cultures compared to isogenic WT controls and we have validated our findings with shRNAs targeting MAPT. Our proposed experiments will use hiPSC-derived neurons and astrocytes to test cell autonomous and non-cell autonomous responses to tau deficiency. These tau deficiency phenotypes include altered granulostasis and the accumulation of double-stranded RNA, as suggested by our preliminary studies. We will also assess electrophysiological function of tau deficient neurons cultured with wild-type astrocytes and wild-type neurons cultured with tau deficient astrocytes. To our knowledge, there are no reports of tau-KO in hiPSC-derived neural cell types, therefore the data generated by this study has the potential to significantly contribute to understanding the role of tau in the central nervous system.
项目摘要/摘要 由MAPT基因编码的Tau蛋白是一种神经元富集的蛋白 微管结合蛋白。 tau蛋白的异常积累是几种神经病理学标志 神经退行性疾病,包括阿尔茨海默氏病(AD)和额叶痴呆症(FTD)。主导的 MAPT基因中的突变存在于遗传的FTD中,表明TAU是神经退行性的因果关系 疾病。但是,这些突变是导致功能丧失,功能获得或获得新颖 功能未知。尽管MAPT中没有引起遗传AD的突变,但是如何 tau功能的改变导致神经细胞功能障碍和tau蛋白的病理聚集是 仍然不完全理解。这些问题尚未得到解决,主要是因为tau的功能 蛋白质尚未得出结论。虽然在神经元中高度表达,但tau在其他 中枢神经系统细胞类型已与从核仁到质膜的细胞局部定位有关。 此外 转运,RNA结合和代谢和细胞骨架元素。这共同表明了tau蛋白的作用 在中枢神经系统细胞中,微管稳定。许多研究检查了 病理tau,但只有有限的研究研究了野生型的细胞功能, 内源性tau。在没有TAU的情况下检查细胞表型是一种理解其正常的方法 功能。迄今为止,大多数研究都使用啮齿动物模型研究了Tau缺乏症或转化的人类细胞系 这些研究表明了各种矛盾的结果。在这项研究中,我们将使用我们的专业知识 人类诱导的多能干细胞技术研究人类神经培养和皮质中Tau功能的丧失 器官。我们将使用CRISPR/CAS9破坏人类Tau阅读框架,从而产生tau-ko细胞系。我们 然后将纯化无偏的转录组分析和基于假设的实验检查分子 神经元和星形胶质细胞缺乏Tau表达的身体后果。我们已经产生了飞行员 数据表明在tau-ko皮质培养物中涉及神经免疫功能的途径的强烈上调 与等源性WT对照相比,我们已经用靶向MAPT的SHRNA验证了我们的发现。我们的 提出的实验将使用HIPSC衍生的神经元和星形胶质细胞来测试细胞自主和非细胞 对tau缺乏的自主反应。这些tau缺乏表型包括改变的肉芽肿和 正如我们的初步研究所建议的,双链RNA的积累。我们还将评估 用野生型星形胶质细胞和野生型神经元培养的Tau缺乏神经元的电生理功能 用tau缺乏的星形胶质细胞培养。据我们所知,没有关于HIPSC衍生的Tau-Ko的报道 神经细胞类型,因此本研究产生的数据有可能显着贡献 了解Tau在中枢神经系统中的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jessica Elaine Young其他文献

Jessica Elaine Young的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jessica Elaine Young', 18)}}的其他基金

Engineering Human Brain Neurovascular Niche for Modeling Brain Diseases
工程人脑神经血管生态位以模拟脑疾病
  • 批准号:
    10478162
  • 财政年份:
    2021
  • 资助金额:
    $ 26.99万
  • 项目类别:
Engineering Human Brain Neurovascular Niche for Modeling Brain Diseases
工程人脑神经血管生态位以模拟脑疾病
  • 批准号:
    10303483
  • 财政年份:
    2021
  • 资助金额:
    $ 26.99万
  • 项目类别:
Role of HDAC2 as a modulator of aging and Alzheimer's disease phenotypes in stem-cell derived neurons
HDAC2 作为干细胞衍生神经元衰老和阿尔茨海默氏病表型调节剂的作用
  • 批准号:
    10377380
  • 财政年份:
    2019
  • 资助金额:
    $ 26.99万
  • 项目类别:
Role of HDAC2 as a modulator of aging and Alzheimer's disease phenotypes in stem-cell derived neurons
HDAC2 作为干细胞衍生神经元衰老和阿尔茨海默氏病表型调节剂的作用
  • 批准号:
    10620637
  • 财政年份:
    2019
  • 资助金额:
    $ 26.99万
  • 项目类别:
Probing the role of SORL1 and endosomal network genetic variation on Alzheimer's disease phenotypes in human neurons.
探讨 SORL1 和内体网络遗传变异对人类神经元阿尔茨海默病表型的作用。
  • 批准号:
    10433931
  • 财政年份:
    2018
  • 资助金额:
    $ 26.99万
  • 项目类别:
Probing the role of SORL1 and endosomal network genetic variation on Alzheimer's disease phenotypes in human neurons.
探讨 SORL1 和内体网络遗传变异对人类神经元阿尔茨海默病表型的作用。
  • 批准号:
    9982742
  • 财政年份:
    2018
  • 资助金额:
    $ 26.99万
  • 项目类别:
Probing the role of SORL1 and endosomal network genetic variation on Alzheimer's disease phenotypes in human neurons.
探讨 SORL1 和内体网络遗传变异对人类神经元阿尔茨海默病表型的作用。
  • 批准号:
    10221575
  • 财政年份:
    2018
  • 资助金额:
    $ 26.99万
  • 项目类别:

相似海外基金

Small Molecule Degraders of Tryptophan 2,3-Dioxygenase Enzyme (TDO) as Novel Treatments for Neurodegenerative Disease
色氨酸 2,3-双加氧酶 (TDO) 的小分子降解剂作为神经退行性疾病的新疗法
  • 批准号:
    10752555
  • 财政年份:
    2024
  • 资助金额:
    $ 26.99万
  • 项目类别:
Uncovering Mechanisms of Racial Inequalities in ADRD: Psychosocial Risk and Resilience Factors for White Matter Integrity
揭示 ADRD 中种族不平等的机制:心理社会风险和白质完整性的弹性因素
  • 批准号:
    10676358
  • 财政年份:
    2024
  • 资助金额:
    $ 26.99万
  • 项目类别:
The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults
终生职业经历对墨西哥老年人认知轨迹的影响
  • 批准号:
    10748606
  • 财政年份:
    2024
  • 资助金额:
    $ 26.99万
  • 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
  • 批准号:
    10749539
  • 财政年份:
    2024
  • 资助金额:
    $ 26.99万
  • 项目类别:
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
  • 批准号:
    10462257
  • 财政年份:
    2023
  • 资助金额:
    $ 26.99万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了